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ABSTRACT
Multiple members of the tumour necrosis factor superfamily (TNFSF)
regulate the growth and branching of neural processes late in
development, when neurons are establishing and refining
connections. Here, we present the first evidence that a TNFSF
member acts much earlier in development, when axons are growing
to their targets. CD40L transiently enhanced axon growth from
embryonic mouse DRG neurons cultured at this early stage. Early
spinal nerves of embryos lacking the CD40L receptor (Cd40−/− mice)
were significantly shorter in vivo than those of Cd40+/+ littermates.
CD40L was synthesized in early DRG targets and was co-expressed
with CD40 in early DRG neurons. Whereas CD40L enhanced early
axon growth independently of neurotrophins, disruption of a CD40L/
CD40 autocrine loop impaired early neurotrophin-promoted axon
growth. In marked contrast to the widespread regulation of axon and
dendrite growth by CD40L reverse signalling later in development,
CD40-Fc, which activates reverse signalling, had no effect on early
sensory axon growth. These results suggest that CD40 forward
signalling is a novel physiological regulator of early axon growth that
acts by target-derived and autocrine mechanisms.
KEY WORDS: TNF superfamily, CD40, CD40L, Sensory axons,
Tissue innervation, Mouse
INTRODUCTION
The growth and elaboration of neural processes in the developing
nervous system is regulated by a variety of extracellular signalling
proteins that act on developing neurons. Much of our understanding
of the principles by which such signals operate has been gained by
studying neurons of the peripheral nervous system (PNS). The most
extensively characterized signals are those provided by members of
the nerve growth factor (NGF) family of neurotrophins, which
include NGF, brain derived neurotrophic factor (BDNF),
neurotrophin 3 (NTF3) and neurotrophin 4 (NTF4). These
secreted proteins are expressed in a variety of tissues and not only
sustain the survival of different kinds of neurons but also promote
the growth and ramification of axons in target tissues (Davies, 2003;
Dekkers and Barde, 2013; Glebova and Ginty, 2005; Huang and
Reichardt, 2001). Because of this, neurotrophins play key roles in
regulating the number of neurons that survive during development
and in controlling tissue innervation density.
Work over the past decade has revealed that multiple members of
the tumour necrosis factor superfamily (TNFSF) are physiological
regulators of axon growth without affecting neuronal survival. The
19 members of this superfamily have been most extensively
characterized in the immune system (Hehlgans and Pfeffer, 2005;
Šedý et al., 2014). They are synthesized as type 2 membrane
glycoproteins that bind to one or more members of the TNF receptor
superfamily (TNFRSF). They exert their actions as membrane-
bound ligands and as soluble ligands following proteolytic cleavage
and release of the extracellular receptor-binding domain from the
cell membrane (Grivennikov et al., 2006; Hehlgans and Pfeffer,
2005). In the developing PNS, it has been reported that members of
the TNFSF act on neurons well after they become dependent on
neurotrophins for survival, during the stage when their axons are
ramifying and refining terminations in target tissues. Whereas some
TNFSF members enhance axon growth (McWilliams et al., 2017;
O’Keeffe et al., 2008; Osório et al., 2014), others reduce the axon
growth-promoting actions of neurotrophins (Gavalda et al., 2009;
Gutierrez et al., 2013). They act on particular kinds of neurons either
in a target-derived manner or via autocrine signalling loops.
In addition to functioning as ligands, several membrane-integrated
TNFSF members can act as reverse signalling receptors for the
TNFRSFmembers towhich they bind. TNFSF reverse signalling has
been widely documented in the immune system (Sun and Fink, 2007)
and has recently been shown to regulate the growth of neural
processes in the developing nervous system. TNFR1 (TNFRSF1A)-
activated TNF reverse signalling enhances the growth of sympathetic
and sensory axons and promotes tissue innervation (Kisiswa et al.,
2013, 2017; Wheeler et al., 2014). BCMA (TNFRSF17)-activated
TWE-PRIL (TNFSF12-TNFSF13) reverse signalling suppresses
sympathetic axon growth and tissue innervation (Howard et al.,
2018). CD40-activated CD40L (CD40LG) reverse signalling is
extensively involved in regulating both axon and dendrite growth in
the developing PNS and CNS. It enhances axon growth from a subset
of sympathetic neurons and hippocampal pyramidal neurons and
selectively regulates the sympathetic innervation of particular tissues
in vivo (Carriba and Davies, 2017; McWilliams et al., 2015). CD40-
activated CD40L reverse signalling is a major in vivo regulator of
dendrite growth and arborization in the CNS, promoting the growth
and elaboration of excitatory neuron dendrites and suppressing the
growth and elaboration of inhibitory neuron dendrites (Carriba and
Davies, 2017).
Here, we have focused on the sensory neurons of developing
mouse dorsal root ganglia (DRG). These neurons are derived from
the neural crest and extend axons to central targets in the spinal cord
and peripheral targets in developing skin and a great variety of other
tissues (Lallemend and Ernfors, 2012). Newly differentiated
sensory neurons survive and extend axons independently of
neurotrophins when their axons are growing to their targets andReceived 4 February 2019; Accepted 14 August 2019
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become dependent on neurotrophins for survival as their axons
reach their targets (Davies et al., 1987; Vogel and Davies, 1991).
Survival dependence on particular neurotrophins becomes restricted
to functionally distinct subsets of DRG neurons as development
progresses (Ernsberger, 2009). Although subsets of neurotrophin-
dependent DRG neurons subsequently acquire survival responses to
members of glial cell-derived neurotrophic factor (GDNF) in late
fetal development in vitro (Baudet et al., 2000), these factors play no
role in sustaining the survival of all but a very small functional
subset of DRG neurons in vivo (Fleming et al., 2015). There is
evidence, however, that the GDNF family play a role in specifying
functional subsets of DRG neurons (Ernsberger, 2008, 2009;
Lallemend and Ernfors, 2012).
In this publication, we report that CD40L-activated CD40 forward
signalling is a physiological regulator of axon growth, but not neuron
survival, for developing DRG neurons. However, in contrast to all
other TNFSF members, which regulate axon growth during a late
developmental window well after axons have reached their target
tissues and are ramifying in and refining terminations in these tissues,
CD40 forward signalling acts very early and transiently in
development when DRG axons are growing to their targets.
RESULTS
CD40L enhances early in vitro DRG axon growth
independently of neurotrophins
To study the potential effect of CD40L on axon growth from
developing sensory neurons, we established low-density dissociated
cultures of embryonic mouse DRG neurons over a range of ages
beginning at embryonic day (E)11, the earliest age at which DRG can
be reliably dissected from embryos. To prevent neuronal apoptosis,
we included the pan-caspase inhibitor Boc-D-FMK in the culture
medium. Neurons in these cultures exhibited the characteristic bipolar
morphology of early sensory neurons (Fig. 1A). In E11 cultures,
when the earliest DRG axons are growing to their targets in vivo,
CD40L significantly enhanced axon growth at only the highest
concentration used (1 µg/ml) (Fig. 1B). In E12 cultures, the neurons
exhibited enhanced sensitivity to CD40L, with a significant increase
of axon lengthwith levels of CD40L as low as 1 ng/ml (Fig. 1C). This
response to CD40L was, however, very transient. By E13, the
neurons had lost responsiveness to CD40L at all but the highest
concentration used (Fig. 1D), and at later ages no response to CD40L
was observed (Fig. 1E). Although CD40L is the main ligand for
CD40, Hsp70 (Hspa1b) can also function as a CD40 ligand that
modulates CD40 activity (Wang et al., 2001; Becker et al., 2002).
However, Hsp70 at concentrations ranging from 1 ng/ml to 1 µg/ml
had no effect on early sensory axon growth (not shown), suggesting
that Hsp70 does not modulate early sensory axon growth.
Neural crest-derived sensory neurons, such as DRG and trigeminal
ganglion neurons, respond to neurotrophins in development. In
cultures set up at sequential stages of development, neurons initially
survive and extend axons independently of neurotrophins before
responding to BDNF. Shortly after, they begin responding to NGF
with the arrival of the earliest peripheral axons at their cellular targets
(Buchman and Davies, 1993; Davies et al., 1987). This temporal
sequence of neurotrophin responsiveness is due in part to the earlier
birth of BDNF-responsive neurons and partly because some neurons
switch responsiveness from BDNF to NGF early in development
(Enokido et al., 1999).
To compare the timing of CD40L responsiveness with
neurotrophin responsiveness, we studied the effect of BDNF, NGF
and CD40L in cultures set up at different ages. In E11 cultures,
BDNF promoted a very marked axon growth response (Fig. 1B). By
E12 the response to BDNF had greatly decreased and a marked
response to NGF had become apparent (Fig. 1C). Although the
magnitude of the axon growth response to CD40L had also increased
by E12, this response was less than that elicited by NGF, even at the
highest concentration of CD40L used (Fig. 1C). In E12 cultures, there
was no additive effect of saturating concentrations of CD40L with
either BDNF or NGF (Fig. 1F), suggesting that the neuronal
populations that respond to neurotrophins and CD40L were
overlapping.
CD40L does not affect DRG neuron survival
In the absence of Boc-D-FMK, the majority of E12 neurons
underwent apoptosis in control cultures (no added factors) by 24 h
incubation (Fig. 1G). In contrast to the pronounced survival response
of the majority of neurons to NGF, there was no significant difference
in survival between control cultures and CD40L-supplemented
cultures (Fig. 1G). Therewas no additional survival in cultures treated
with CD40L plus NGF, compared with NGF-treated cultures, and
there was no significant difference in survival between cultures
treated with CD40L plus BDNFand control cultures (Fig. 1G). Taken
together, these findings suggest that CD40L enhances the growth of
axons from early DRG neurons independently of neurotrophins at the
stage when axons are growing to their targets in vivo, without
affecting neuron survival.
CD40L enhances early axon growth by CD40-mediated
forward signalling in vitro
To clarify the manner by which CD40L stimulates axon growth
from early DRG neurons, we studied axon growth from E12 DRG
neurons cultured from Cd40−/− embryos and Cd40+/+ littermates in
the absence of NGF but with Boc-D-FMK to sustain survival. The
marked axon growth response of neurons cultured from Cd40+/+
mice to soluble CD40L was completely eliminated in neurons
cultured from Cd40−/− mice (Fig. 2). There was no significant
difference in axon length between neurons cultured from Cd40−/−
mice grown with and without CD40L (Fig. 2A). A soluble CD40-Fc
chimera (in which the extracellular domain of CD40 is linked to the
Fc part of human IgG1) that activates CD40L-mediated reverse
signalling (Carriba and Davies, 2017; McWilliams et al., 2015) did
not significantly affect axon growth. There was no significant
difference in axon length between neurons that were treated with a
concentration of CD40-Fc (1 µg/ml) that has previously been shown
to activate reverse signalling in neurons and neurons treated with the
same concentration of Fc control protein (Fig. 2A). To be sure of
this point, we performed an extensive dose-response analysis using
CD40-Fc at concentrations ranging from 0.1 to 10 µg/ml. CD40-Fc
did not significantly affect axon growth at any concentration within
this range (data not shown). The appearance of representative DRG
neurons cultured from E12 Cd40−/− and Cd40+/+ embryos grown
for 24 h with and without CD40L are shown in Fig. 2B. Taken
together, these results suggest that CD40L promotes early sensory
axon growth by activating CD40-mediated forward signalling.
Decreased in vivo length of spinal nerves ofCd40−/− embryos
To ascertain the physiological significance of our in vitro
observations, we used immunolabelling-enabled three-dimensional
imaging of solvent-cleared organs (iDISCO) (Renier et al., 2014) to
visualize and compare spinal nerves in Cd40−/− embryos and
Cd40+/+ littermates. Axons were labelled using an antibody against
the neuron-specific marker βIII-tubulin (Tubb3). Embryos were
studied at three stages of development: E11, E12 and E13. Although
the gross anatomy of the spinal nerves was similar in Cd40−/− and
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Cd40+/+ embryos at each age (Fig. 3A), the spinal nerves emerging
from DRG were significantly shorter in Cd40−/− embryos compared
with Cd40+/+ embryos. Nerve length was most accurately quantified
by measuring the length between the distal tips of segmental spinal
nerves and the point at which the central rami of the DRG contact the
spinal cord for the same lower thoracic DRG. Blind quantification
revealed highly significant reductions in nerve length in Cd40−/−
embryos compared with Cd40+/+ embryos at each age (Fig. 3B). To
provide an additional level of quantification, we compared the overall
size of the hind limb plexus in both genotypes at E12 and E13 when
the plexus starts forming by quantifying the intensity of βIII-tubulin
immunolabelling in a standardized region centred on the plexus. This
Fig. 1. CD40L enhances axon growth from early DRG
neurons. (A) Representative images of E12 DRG neurons
cultured for 24 h with and without 100 ng/ml CD40L. Scale bar:
100 µm. (B-E) Length of axons growing from E11 (B), E12 (C),
E13 (D) and E15 (E) DRG neurons cultured for 24 h with either
different concentrations of CD40L, 10 ng/ml NGF, 10 ng/ml BDNF
or no factors. (F) Length of axons growing from E12 DRG neurons
cultured for 24 h with either 100 ng/ml CD40L, 10 ng/ml NGF,
10 ng/ml BDNF, NGF plus BDNF, CD40L plus NGF, CD40L plus
BDNF or no added factors. All cultures (A-F) received 25 µM Boc-
D-FMK. Data are mean±s.e.m. of >50 neurons per condition
obtained from three separate experiments. (G) Percent survival of
E12 DRG neurons after 24 h in cultures without Boc-D-FMK,
normalized to 100% survival for NGF-supplemented cultures.
Data are mean±s.e.m. from three separate experiments. *P<0.05,
**P<0.01, ***P<0.001; one-way ANOVA with Bonferroni
correction, comparison with control.
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analysis revealed highly significant reductions in immunolabelling in
Cd40−/− embryos compared with Cd40+/+ embryos at both ages
(Fig. 3C).
To exclude the possibility that differences in nerve length were
secondary to differences in the number of neurons in the DRG of
Cd40−/− and Cd40+/+ embryos, we quantified the number of
neurons in a standard DRG (L4) in E12 Cd40−/− and Cd40+/+
littermates. This analysis revealed no significant differences in
neuron number between Cd40−/− and Cd40+/+ mice (Fig. 3D). This
result is consistent with the lack of effect of CD40L on the survival
of DRG neurons (Fig. 1G). Taken together, our finding that
Cd40−/− embryos exhibit a phenotype in vivo that matches the effect
of soluble CD40L on early DRG axon growth in vitro demonstrates
the physiological relevance of these findings.
Although Cd40−/− and Cd40+/+ embryos were anatomically
similar, to exclude the possibility that differences in size between
Cd40+/+ and Cd40−/− embryos could account for differences in
sensory nerve length, we measured the length of a defined region of
the sympathetic chain in E11 Cd40+/+ and Cd40−/− embryos. In
contrast to sensory fibre length, there was no significant difference
between sympathetic chain length inCd40+/+ and Cd40−/− embryos
(Fig. S1).
Expression of Cd40lmRNA in DRG and peripheral targets
Neurons could potentially obtain CD40L in vivo locally and/or from
their targets. To address these possibilities, we used reverse
transcription-qPCR (RT-qPCR) to quantify the relative levels of
Cd40l mRNA in DRG and DRG targets (hind limb buds) dissected
from embryos at stages during the period when DRG axons are
emerging from DRG and are growing toward and reaching their
targets in vivo (E11 to E15). Because Cd40l mRNA is difficult to
detect by conventional qPCR, we used a nested primer approach.
Cd40l mRNA was clearly detected in DRG at E11. Relative to the
geometric means of mRNAs encoding three housekeeping proteins
(glyceraldehyde phosphate dehydrogenase, succinate dehydrogenase
and hypoxanthine phosphoribosyltransferase 1) the level of Cd40l
mRNA in DRG decreased markedly with age, becoming almost
undetectable by E15 (Fig. 4A). In contrast, Cd40l mRNA was
undetectable in hind limb buds at E11 (Fig. 4B). It was first detected at
E12 and its relative level increased at older ages to reach amaximum at
E15 (Fig. 4B). These findings suggest that CD40L is first synthesized
locally in DRG when axons are starting to grow to their targets. At
later ages, as DRG axons reach their targets, CD40L synthesis begins
and increases in target tissues and decreases locally in DRG.
Expression of Cd40mRNA in DRG and peripheral targets
We have shown that CD40L-activated CD40-mediated forward
signalling enhances DRG axon growth during a brief period of
early development. To investigate whether the timing of CD40L
responsiveness is controlled by receptor expression, we used
RT-qPCR to measure the level of Cd40 mRNA in early DRG as an
indirect measure of CD40 expression. Cd40 mRNA was detected in
early DRG at all stages studied, with a clear peak in expression at E12
followed by a marked decrease (Fig. 4C). The peak in Cd40 mRNA
expression coincides with maximum responsiveness of cultured DRG
to CD40L, suggesting that the timing of CD40 expression may
influence the timing of CD40L responsiveness. For completeness we
also measured the relative levels of Cd40 mRNA in limb buds.
Surprisingly, Cd40 mRNAwas detectable at each age studied, with a
gradual decrease in expression with age (Fig. 4D).
Immunochemical localization of CD40 and CD40L proteins
The expression of Cd40l and Cd40mRNAs in early DRG raised the
question of which cells express CD40L and CD40 and the cellular
distribution of these molecules. We visualized the location of CD40
and CD40L using immunocytochemistry in dissociated cultures of
E12 DRG neurons. The specificity of the anti-CD40 antibody was
demonstrated by the elimination of CD40 immunofluorescence in
cultures established fromCd40−/− embryos (Fig. S2). Although early
DRG comprise predominantly neurons, we were particularly
interested in ascertaining whether CD40 and CD40L are expressed
in different subpopulations or are co-expressed. Double labellingwith
the neuronal marker anti-βIII-tubulin revealed that virtually all
neurons expressed CD40 (94.6±2.4%, data are mean±s.e.m.)
(Fig. 4E) and CD40L (92.2±3.2%) (Fig. 4F). This suggests that
neurons co-express CD40 and CD40L. To formally demonstrate this,
we double labelled cells with anti-CD40L and anti-CD40. These
studies showed that virtually all cells were labelled by both anti-
CD40L and anti-CD40 (Fig. 4G), suggesting that early DRG neurons
co-express CD40 and CD40L. This in turn raised the possibility of
CD40L/CD40 autocrine signalling in early DRG neurons.
The distribution of CD40 immunolabelling and CD40L
immunolabelling was noticeably different on early DRG neurons.
CD40 immunolabelling was clear both at the cell body of the
neurons and along their axons (Fig. 4E). In contrast, CD40L
Fig. 2. Deletion of the Cd40 gene eliminates the CD40L axon growth
response. (A) Axon length of E12 DRG neurons of Cd40−/− and Cd40+/+
littermates cultured for 24 h with 25 µM Boc-D-FMK. In addition to controls
(which received no additional reagents), the cultures received either 100 ng/ml
CD40L, 1 µg/ml CD40-Fc or 1 µg/ml control Fc protein. Data are mean±s.e.m.
of >50 neurons per condition obtained from three separate experiments.
***P<0.001, t-test. (B) Representative images of E12 DRG neurons ofCd40−/−
andCd40+/+ littermates after 24 h in cultures supplemented with 25 µMBoc-D-
FMK and either with no added reagents (controls) or 100 ng/ml CD40L. Scale
bar: 100 µm.
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immunolabelling was clearly evident at the cell body, but was either
very low or negligible along the axons (Fig. 4F). This pattern is
opposite to that observed on cultured sympathetic neurons using the
same antibodies, where CD40L immunolabelling is clear both at the
cell body and along axons and CD40 immunolabelling is clear at the
cell body but very low or negligible along axons (McWilliams et al.,
2015). The significance of these different distributions is unclear.
We performed immunohistochemical localization studies on
sectioned embryonic DRG to compliment the above
immunocytochemical studies. Although we were unable to find an
anti-CD40L antibody that works reliably on sections, anti-CD40
clearly labelled neurons in sections of E12 DRG (Fig. 4H).
CD40L/CD40 autocrine signalling contributes to
neurotrophin-promoted axon growth
The co-expression of CD40 and CD40L by early DRG raises the
possibility that axon growth may be influenced by a CD40L/CD40
autocrine signalling loop in these neurons. The similarity in axon
length between Cd40−/− and Cd40+/+ DRG neurons grown without
neurotrophins (Fig. 2) suggests that CD40L/CD40 autocrine
signalling does not contribute to the low level of axon growth
occurring from early DRG neurons in the absence of neurotrophins.
To test whether CD40L/CD40 autocrine signalling contributes to
the magnitude of neurotrophin-promoted axon growth, we
measured the axon lengths of DRG neurons of Cd40−/− and
Cd40+/+ embryos incubated with a range of concentrations of
BDNF at E11 and NGF at E12. These dose responses showed that
neurons from wild-type embryos are an order of magnitude more
sensitive to BDNF at E11 than to NGF at E12 (reaching maximal
responsiveness at concentrations of approximately 0.01 and
0.1 ng/ml, respectively) (Fig. 5A,B). There was no significant
difference in axon length between Cd40−/− and Cd40+/+ neurons
grown with no or low concentrations of neurotrophins. However,
with higher concentrations (0.01-10 ng/ml BDNF and 0.1-10 ng/ml
Fig. 3. Decreased in vivo length of
spinal nerves of Cd40−/− embryos.
(A) Representative iDISCO images of
E11, E12 and E13 embryos of Cd40−/−
and Cd40+/+ littermates labelled with
anti-βIII-tubulin. Arrows indicate the
distal tips of spinal nerves. FL, fore limb;
HL, hind limb. The standardized regions
in which hind limb plexus βIII-tubulin
immunoreactivity was assessed in E13
embryos is indicated by the dashed
circles. Scale bars: 200 µm. (B) Scatter
plots of the measurements between the
distal tips of mid-thoracic spinal nerves
and the point at which the corresponding
spinal roots contact the spinal cord,
normalized to 100% for the Cd40+/+
mean at each age. Each point represents
the mean measurement from individual
embryos at E11, E12 and E13.
(C) Scatter plots of hind limb plexus βIII-
tubulin immunoreactivity normalized to
100% for the Cd40+/+ mean at E12 and
E13. (D) Bar chart of the numbers of
neurons in the L4 DRG of E12 Cd40−/−
and Cd40+/+ littermates (n=4 embryos
per genotype). Data are mean±s.e.m.
*P<0.05, **P<0.01, ***P<0.001; t-test,
comparison between Cd40−/− and
Cd40+/+ embryos at each age.
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NGF), neurons of Cd40−/− embryos had significantly shorter axons
than those of Cd40+/+ littermates (Fig. 5A,B). This suggests that
disruption of a putative CD40L/CD40 autocrine loop by deleting
Cd40 impairs the growth of axons from DRG neurons stimulated
with either BDNF or NGF.
An alternative way of eliminating CD40L/CD40 autocrine
signalling was to prevent interaction of endogenous CD40L and
CD40 in wild-type neurons by treating these neurons with function-
blocking antibodies to CD40L and CD40 (McWilliams et al., 2015).
In these experiments, we measured the axon lengths of E11 and E12
DRG neurons incubated with a range of concentrations of BDNF
and NGF in cultures supplemented with either function-blocking
antibodies or isotype control immunoglobulin. The axon growth
dose responses of neurons incubated with isotype control
immunoglobulin were very similar to those of Cd40+/+ neurons
and the axon growth dose responses of neurons incubated with
function-blocking antibodies were very similar to those of Cd40−/−
neurons. Significant differences in axon length between control-
treated and function-blocking antibody-treated neurons were
observed at concentrations of BDNF of 0.01 ng/ml and greater
and at concentrations of NGF of 0.1 ng/ml and greater (Fig. 5C,D).
The function blocking anti-CD40 and anti-CD40L antibodies were
just as effective when used singularly as in combination (Fig. 5F).
To exclude the possibility that our results could have been
influenced by the use of the pan-caspase inhibitor Boc-D-FMK to
prevent neuronal death, we used an alternative way of preventing
neuronal death in cultures that contained low levels or no
neurotrophins. Neurons that lack that pro-apoptotic protein BAX
fail to undergo apoptosis in the absence of NGF (Deckwerth et al.,
1996). Similar results to those obtained from wild-type neurons in
which death was prevented with Boc_D_FMK were obtained using
neurons dissected from Bax−/− embryos grown in the absence of
Boc-D-FMK (Fig. 5E). Taken together, our findings support the
view that a CD40L/CD40 autocrine signalling loop contributes to
the magnitude of neurotrophin-promoted axon growth.
Mechanism of action
Because early DRG neurons respond to neurotrophins, one
mechanism by which CD40L might affect neurite growth is by
modulating expression of NGF and BDNF receptor tyrosine kinases.
However, there was no significant difference in the levels of TrkA
(Ntrk1) mRNA and TrkB (Ntrk2) mRNA measured using qPCR in
DRG dissected from Cd40−/− and Cd40+/+ embryos (Fig. S3A,B)
and no obvious difference in TrkA and TrkB immunocytochemistry
in dissociated cultures established from Cd40−/− and Cd40+/+
embryos (Fig. S3C,D).
Fig. 4. Expression of CD40 and CD40L. (A-D) Graphs of the levels of Cd40lmRNA (A,B) and Cd40mRNA (C,D) in the DRG (A,C) and hind limbs (B,D) of E11,
E12, E13 and E15 embryos relative to the geometric mean of referencemRNAs forGapdh,Sdha andHprt1. The data are normalized to 1.0 for the highest level of
expression of Cd40l mRNA and Cd40 mRNA for each age series. (E-G) Representative photomicrographs of low-density E12 DRG neuron cultures double
labelled with either anti-CD40 and anti-βIII-tubulin (E), anti-CD40L and anti-βIII-tubulin (F) or anti-CD40 and anti-CD40L (G). All cultures were also stained with the
nuclear marker DAPI. Scale bar: 20 µm. (H) Representative low and high power immunohistochemical images of sectioned E12 DRG stained with anti-CD40
antibody. Scale bars: 100 µm (left) and 50 µm (right).
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Because ERK signalling contributes to neurotrophin-promoted
axon growth (Atwal et al., 2000; O’Keeffe et al., 2008) and because
CD40 signalling modulates neurotrophin responsiveness (Fig. 5),
we investigated whether ERK signalling contributes to CD40L-
promoted axon growth. We first tested whether CD40L activates
ERK1 and ERK2 in cultured DRG neurons. In these experiments,
we cultured E12 DRG neurons for 12 h with the caspase inhibitor
Boc-D-FMK before treating them with either CD40L or NGF as
Fig. 5. Disruption of the putative CD40L/CD40 autocrine signalling loop decreases the axon growth response to high neurotrophin concentrations.
(A,B) Graphs of axon length of E11 (A) and E12 (B) DRG neurons of Cd40−/− and Cd40+/+ littermates cultured for 24 h with and without BDNF (A) or NGF (B) at
concentrations ranging from 0 to 10 ng/ml. (C,D) Graphs of axon length of E11 (C) and E12 (D) DRG neurons cultured for 24 h with a range of BDNF or NGF
concentrations plus either function-blocking anti-CD40L and function-blocking anti-CD40 antibodies or isotype controls (each at 2 μg/ml). All cultures also
received 25 µM Boc-D-FMK. (E) Axon lengths of E12 DRG BAX-deficient neurons cultured with a range of NGF concentrations together with either function-
blocking anti-CD40L and function-blocking anti-CD40 antibodies or isotype controls (each at 2 μg/ml). (F) Axon lengths of E12 DRG neurons cultured with
10 ng/ml NGF and function-blocking anti-CD40L and anti-CD40 antibodies alone or in combination or with isotype controls (each at 2 μg/ml) plus 25 µM
Boc-D-FMK. Data are mean±s.e.m. of >50 neurons per condition combined from three experiments of each type. **P<0.01, ***P<0.001; one-way ANOVA,
statistical comparison at each BDNF or NGF concentration.
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positive control. Western blotting revealed that CD40L caused rapid
increases in the amounts of phospho-ERK1 and phospho-ERK2
within 10 min, which returned to basal levels within 30 min
(Fig. 6A,B). Densitometry of multiple blots revealed that activation
of ERK by CD40L was of similar magnitude to that NGF. These
results show that CD40L causes rapid, transient activation of ERK1
and ERK2 independently of NGF.
To investigate whether ERK1 and ERK2 activation is responsible
for the enhanced axon growth brought about by CD40L, we
examined whether U0126, a selective MEK1 and MEK2 inhibitor
that interferes with MEK1- and MEK2-dependent activation of
ERK1 and ERK2 (Favata et al., 1998), could prevent CD40L-
promoted axon growth. In these experiments, we plated E12 DRG
neurons in NGF-free medium containing Boc-D-FMK and pre-
treated these neurons for 1 h with either U0126 or the inactive
analogue U0124 before adding CD40L and quantifying the axon
length 24 h later. U0126, but not U0124, completely prevented
CD40L-enhanced axon growth (Fig. 6C). This suggests that MEK/
ERK signalling has a crucial role in mediating the effect of CD40L
on axon growth.
Because the axon growth response of DRG neurons to
neurotrophins is reduced in CD40-deficient neurons (Fig. 5), we
investigated whether CD40 signalling affects the magnitude of ERK
activation by NGF. In these experiments, DRG neurons from E12
Cd40−/− andCd40+/+ embryos were cultured for 12 h in the presence
of Boc-D-FMK before being stimulated with 0, 0.1 or 10 ng/ml NGF
for 30 min.Western blotting revealed that ERK activation occurred in
response to NGF in neurons of both genotypes (Fig. 6D) but was
significantly lower in neurons in CD40-deficient neurons (Fig. 6E).
These results suggest that CD40 signalling contributes to NGF-
promoted ERK activation.
DISCUSSION
We have shown that CD40L is a key regulator of sensory axon
growth at an early stage of development. In culture, CD40L
enhances axon growth from dissociated DRG neurons
independently of neurotrophins at the stage of development when
DRG axons are growing to their peripheral targets. This effect is
very transient, beginning when neurons start responding to BDNF
and NGF. It is virtually over by E13, whenmany axons have reached
their targets and have become NGF-dependent. In common with
other members of the TNFSF that regulate axon growth, either by
forward or reverse signalling mechanisms (Desbarats et al., 2003;
Gavalda et al., 2009; Gutierrez et al., 2008, 2013; Kisiswa et al.,
Fig. 6. CD40L activates ERK1/ERK2 and enhances ERK1/ERK2 activation by NGF. (A) Representative western blots probed for phospho-ERK1/2, total
ERK1/2 and βIII-tubulin of lysates of E12 DRG neurons grown for 12 h with 25 µM Boc-D-FMK and stimulated with either 100 ng/ml CD40L for the indicated times
or 10 ng/ml NGF for 30 min. (B) Densitometry of phospho-ERK1/2 bands from three separate experiments. (C) Lengths of E12 DRG neurons that had
been pre-incubated with 10 µM of either U0124 or U0126 for 1 h then incubated for 24 h with either no factors, 100 ng/ml CD40L or 10 ng/ml NGF. All cultures also
received 25 µM Boc-D-FMK. Data are mean±s.e.m. of >50 neurons per condition combined from three experiments of each type. ***P<0.001; one-way ANOVA,
statistical comparison between U0124-treated and U0126-treated cultures. (D) Representative western blots probed for phospho-ERK1/2, total ERK1/2
and βIII-tubulin of lysates of E12 DRG cultures established fromCd40−/− andCd40+/+ littermates grown for 12 h with 25 µMBoc-D-FMK and stimulated with either
0, 0.1 or 10 ng/ml NGF for 30 min. (E) Densitometry of phospho-ERK1/2 bands. Data are mean±s.e.m. from three experiments. **P<0.01; one-way ANOVA,
statistical comparison between genotypes.
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2013, 2017; McWilliams et al., 2015; O’Keeffe et al., 2008;
Wheeler et al., 2014), and in marked contrast to neurotrophins
(Davies, 2003), CD40L has no effect on neuronal survival.
Importantly, we observed a phenotype that matched these in vitro
findings in mice lacking CD40, the receptor for CD40L. During the
periodof developmentwhenDRGaxons are growing toward and start to
reach their peripheral targets, spinal nerves were significantly shorter in
Cd40−/− embryos compared with Cd40+/+ littermates. Highly
significantly reductions in thoracic nerve length in Cd40−/− embryos
compared with Cd40+/+ embryos were observed at each age studied
(E11, E12 and E13) and there were also significant reductions in hind
limb plexus complexity in Cd40−/− embryos at E12 and E13. These
in vivo observations confirm the physiological relevance of our in vitro
findings. However, although the relative reduction in thoracic nerve
length in Cd40−/− embryos was proportionately greater at E12 than at
E13, the relative reduction in hind limb plexus complexity was
proportionately greater at E13 than at E12. Whether these age-relative
regional differences in relativemagnitude of the significant effects of the
Cd40nullmutation reflect statistical variationor possiblysomedegree of
compensation in the thoracic nerves of Cd40−/− embryos is unclear.
The early developmental effect of CD40L on sensory axon growth
is in marked contrast to the actions of other members of the TNFSF
that regulate sensory and sympathetic axon growth in the developing
PNS. In all studies to date, TNFSF members acting by either forward
or reverse signalling influence axon growth much later in
development, well after neurons have become dependent on
neurotrophins for survival when their axons are ramifying in and
refining terminations in their targets (Desbarats et al., 2003; Gavalda
et al., 2009; Gutierrez et al., 2008, 2013; Howard et al., 2018; Kisiswa
et al., 2013, 2017; McWilliams et al., 2015; Nolan et al., 2014;
O’Keeffe et al., 2008; Wheeler et al., 2014). In addition to regulating
axon growth by either forward or reverse signalling mechanisms,
TNFSF members also regulate the extent of axon branching in vitro
(Gavalda et al., 2009; Gutierrez et al., 2008, 2013; Howard et al.,
2018; Kisiswa et al., 2013; McWilliams et al., 2015; O’Keeffe et al.,
2008). This in turn influences target field innervation density in vivo
(Howard et al., 2018; Kisiswa et al., 2013; McWilliams et al., 2015;
O’Keeffe et al., 2008; Wheeler et al., 2014). In contrast, we have
shown that CD40L has no effect on DRG axon branching. This may
reflect the early stage of development during which CD40L acts, a
stage in which DRG neurons are normally bipolar and unbranched.
The very early effect of CD40L on sensory axon growth raises the
possibility that CD40L plays a role in guiding sensory axons to their
targets, as has been demonstrated for specific target-derived sensory
axon attractants (Lumsden and Davies, 1983, 1986). However, this
seems to be unlikely because the gross anatomy of sensory fibres
in early Cd40−/− embryos appears to be normal compared with
Cd40+/+ littermates. It therefore appears that the principal role of
CD40L in the developing sensory nervous system is to accelerate the
growth of sensory axons to their targets without influencing the
direction in which they grow.
In addition to the uniquely early stage of development at which
CD40L acts on sensory neurons, CD40L differs from other TNFSF
members in theway it regulates axon growth in the developing PNS.
Other TNFSF members do not affect axon growth in the absence of
neurotrophin signalling, but selectively modulate the axon growth
response of neurons to neurotrophins. Either they enhance the
neurotrophin axon growth response (Kisiswa et al., 2013;
McWilliams et al., 2015; O’Keeffe et al., 2008) or impair this
response (Gavalda et al., 2009; Gutierrez et al., 2008, 2013; Howard
et al., 2018). In contrast, CD40L is able to promote the growth of
early sensory axons in the absence of neurotrophins.
Although CD40L is able to promote axon growth independently of
neurotrophins in early sensory neurons, CD40L/CD40 autocrine
signalling is also able to modulate the axon growth response of these
neurons to neurotrophins. Many neurons co-express a TNFSF
member and the TNFRSF(s) member to which it binds, and
influence the neurotrophin axon growth response by engaging an
autocrine signalling loop (Gavalda et al., 2009; Gutierrez et al., 2008;
McWilliams et al., 2015; O’Keeffe et al., 2008). Early sensory
neurons co-express CD40 and CD40L, and disrupting a putative
CD40L/CD40 autocrine loop in very low-density cultures
significantly reduces the axon growth response to BDNF and NGF.
This suggests that CD40L/CD40 autocrine signalling makes the
neurons significantly more responsive to the axon growth-promoting
ability of these neurotrophins. This enhanced neurotrophin
responsiveness may be part of the reason why early DRG nerve
fibres are shorter in Cd40−/− embryos compared with Cd40+/+
littermates. In addition, the synthesis of CD40L in peripheral target
tissuesmay also enhance axon growth in vivo by acting directly on the
growing axons. The expression of CD40 along the axons of early
sensory neurons suggests that these neurons are potentially capable of
responding to target-derived CD40L. We are unable to comment on
the relative contributions of CD40L/CD40 autocrine signalling and
target-derived CD40L to early sensory axon growth in vivo. However,
the shift in the expression ofCd40lmRNA from neurons to targets in
early development suggests that autocrine signalling predominates
earlier than target-derived CD40L.
A clear difference between our current results and published
studies on CD40 is the direction of signalling. A variety of
experimental approaches have demonstrated that CD40-activated
CD40L-mediated reverse signalling regulates the growth of
sympathetic axons, hippocampal pyramidal neuron axons, medium
spiny neuron dendrites and hippocampal pyramidal neuron dendrites
(Carriba and Davies, 2017; McWilliams et al., 2015). In contrast, our
finding that soluble CD40L enhances sensory axon growth in a
CD40-dependent manner and our demonstration that soluble CD40-
Fc, which activates reverse signalling, has no effect on sensory axon
growth suggests the operation of CD40L-activated CD40-mediated
forward signalling in early sensory neurons. Although CD40 is the
principal receptor for CD40L, it is recognized that CD40L can bind to
other receptors, such as members of the integrin family (Michel et al.,
2017). However, the complete elimination of the CD40L-promoted
axon growth response in CD40-deficient early sensory neurons
suggests that CD40 is the relevant receptor.
The direct neurotrophin-independent effects of CD40L on early
sensory axon growth and its indirect effect of modulating the
sensitivity of the neurons to the axon growth-promoting effects of
neurotrophins appears to be mediated largely by thewell-recognised
axon growth-promoting pathway that includes ERK activation
(Atwal et al., 2000; O’Keeffe et al., 2008). CD40L causes a marked
activation of ERK1/ERK2 that is of similar magnitude to that
promoted by neurotrophins, and pharmacological blockade of
ERK1/ERK2 activation eliminates the axon growth-promoting
effect of CD40L. The efficiency with which neurotrophins promote
ERK1/ERK2 activation is markedly and significantly reduced in
neurons cultured from Cd40−/− embryos. How CD40 signalling
affects ERK activation is an intriguing question for future research.
In summary, we have shown that CD40L-activated CD40-
mediated forward signalling is a novel physiological regulator of
axon growth in the developing nervous system. In striking contrast
to late developmental action of other TNFSF members that regulate
axon growth, CD40L acts very early in neuronal development. The
transient effect of CD40L on DRG neurons declines markedly as
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their axons reach their targets. In future work it will be informative
to see whether CD40-mediated forward signalling operates
elsewhere in the developing nervous system. It will also be
interesting to ascertain whether the early effects of CD40L on
sensory neurons influence future somatosensory function, as this
may provide insights for the selection-advantage of this particular
developmental role of CD40L. It will also be interesting to elucidate
and compare the downstream events from CD40 and CD40L that
mediate the effects of forward and reverse signalling on the growth
of neural processes.
MATERIALS AND METHODS
Animals
This study was conducted on tissues obtained from CD1 wild-type mice
(Mus musculus), Cd40 null mutant mice in a C57BL6/J background that
were purchased from The Jackson Laboratory and Bax null mutant mice (a
gift from Stanley Korsmeyer, Harvard Medical School, Boston, MA, USA).
The mutant mice were back-crossed for at least 10 generations into a CD1
background before undertaking any of the current experimental work.
Cd40+/− mice were crossed to generate Cd40+/+ and Cd40−/− littermates.
Breeding, housing and genotyping was approved by the Cardiff University
Ethical Review Board and was performed within the guidelines of the Home
Office Animals (Scientific Procedures) Act, 1986.
Neuron culture
DRG were dissected from embryonic CD1 mice. The ganglia were
trypsinized and plated at very low density (∼500 neurons per dish) in
poly-ornithine/laminin-coated 35 mm or 4-well tissue culture dishes
(Greiner Bio-One) in serum-free Hams F14 medium (Davies et al., 1993)
supplemented with 0.25% Albumax I (Life Technologies).
Neuronal survival was estimated by counting the number of attached
neurons within a 12×12 mm grid in the centre of each dish 2 h after plating
and again after 24 h, and expressing the 24 h count as a percentage of the 2 h
count. Analysis of neurite length was carried out by labelling the neurons at
the end of the experiment with the fluorescent vital dye Calcein-AM (Life
Technologies). For every condition in each experiment, images of at least 50
neurons were digitally acquired by fluorescence microscopy and analyzed to
obtain total neurite length (Gutierrez and Davies, 2007). Statistical analyses
were performed using a one-way ANOVA with Bonferroni-Holm post hoc
test. Pair-wise comparisons were made using Student’s t-test. NGF, CD40L,
CD40-Fc and Fc control protein were obtained from R&D Systems. The
MEK1 and MEK2 inhibitor U0126 and inactive analogue U0124 were
purchased from Sigma-Aldrich. Where indicated, the culture medium was
supplemented with the caspase inhibitor Boc-D-FMK (Calbiochem) to
prevent neuronal apoptosis in the absence of neurotrophins.
Immunocytochemistry
The culture medium was gently aspirated and the cultures were washed with
PBS at 37°C. Cells were fixed with either ice-cold methanol (MeOH) for
5 min or freshly made 4% paraformaldehyde (Sigma-Aldrich) in 0.12 M
phosphate buffer (pH 7.2) for 12 min. The fixative was removed and, after
washing with PBS, the cultures were blocked for ∼1 h at room temperature
in 5% bovine serum albumin (BSA) containing 0.2% Triton X-100 (Sigma-
Aldrich). The cultures were then incubated overnight at 4°C with primary
antibody in PBS containing 1% BSA (Sigma-Aldrich) and were gently
agitated on an orbital shaker. After extensive washing in PBS, the cultures
were incubated with fluorophore-conjugated secondary antibody (Alexa
Fluor 488/546, Thermo Fisher Scientific) in 1% BSA for 1 h in the dark at
room temperature. Following serial washes in PBS, the nuclei were
counterstained with DAPI (1:10,000, Life Technologies) for 5 min.
The cultures were imaged using either a Zeiss Axiovert 200 Inverted
Fluorescence microscope or a Zeiss LSM 710 Confocal Laser Scanning
Microscope using Zen software (Zeiss). The following primary antibodies
were used: rabbit polyclonal anti-CD40L (1:300, ab2391, Abcam), rabbit
polyclonal anti-CD40 (1:300, ab13545, Abcam), mouse monoclonal anti-
CD40 (1:300, ab91075, Abcam) and mouse monoclonal anti-βIII-tubulin
(1:500, MAB1195, R&D Systems).
Immunohistochemistry
E12 embryos were fixed for 1 h in freshly made 4% PFA, washed in PBS,
and cryoprotected in 30% sucrose in PBS. Embryos were embedded in
Tissue-Tek OCT Compound (Sakura Finetek Europe), in Peel-A-Way
moulds (Ted Pella). Embryos were oriented for sectioning and frozen by
slow immersion in isopentane cooled with dry ice and sectioned using a
Leica CM 1850UV cryostat. Sections were mounted onto Xtra-Adhesive
slides (Surgipath). For immunohistochemical localization of proteins, slides
were washed with PBS, blocked with 5% BSA containing 0.1% Triton
X-100, and incubated overnight with rabbit polyclonal anti-CD40 (1:300,
ab13545, Abcam) in PBS containing 1% BSA. After extensive washing
with PBS, the slides were incubated with fluorophore-conjugated secondary
antibody (1:500, Alexa Fluor 546, Thermo Fisher Scientific) in 1% BSA for
1 h in the dark and imaged using a Zeiss LSM 710 Confocal Laser Scanning
Microscope using Zen software.
Analysis of DRG peripheral fibres in vivo
Analysis of sensory fibre growth in vivo was carried out using iDISCO
preparations (Renier et al., 2014) of E11, E12 and E13Cd40+/+ andCd40−/−
embryos. Briefly, embryos were fixed in 4% paraformaldehyde for 24 h and
serially dehydrated in methanol/phosphate buffered saline (PBS). The
samples were then bleached overnight in chilled 5% H2O2 to reduce tissue
auto-fluorescence before being serially rehydrated in methanol/PBS
containing 0.2% Triton X-100. The embryos were incubated in blocking
solution (6% donkey serum, 20% DMSO, 0.2% Triton X-100, 0.3 M
Glycine in PBS) for 72 h at 37°C. After washing with PBS containing 0.2%
Tween-20 and 10 mg/ml heparin (PTwH), the embryos were incubated with
βIII-tubulin antibody (1:300, MAB1195, R&D Systems) in PTwH
containing 5% DMSO and 3% donkey serum for 72 h at 37°C. Following
extensive washing in PTwH, the samples were incubated with donkey
anti-mouse 546 Alexa Fluor secondary antibody (1:300, A10036, Life
Technologies) in PTwH plus 3% donkey serum for 72 h at 37°C. After
further washing in PTwH, samples were cleared by overnight incubation in
tetrahydrofuran, followed by dichloromethane treatment for 15 min. The
samples were placed in dibenzyl ether (DBE) until clear and imaged while
submerged in DBE in 3D-printed slide chambers using a Zeiss LSM710
confocal microscope. The Cd40−/− data are expressed as a percentage of the
mean of Cd40+/+ data. All imaging and quantification was performed blind
with genotypes determined after quantification.
RT-qPCR
The levels of Cd40l, Cd40, TrkA and TrkB mRNAs were quantified by
qPCR relative to a geometric mean of mRNAs for the housekeeping
enzymes glyceraldehyde phosphate dehydrogenase (Gapdh), succinate
dehydrogenase (Sdha) and hypoxanthine phosphoribosyltransferase 1
(Hprt1). Total RNA was extracted from dissected DRG or hind limb buds
using the RNeasy Micro extraction kit (Qiagen) and 5 μl was reverse
transcribed for 1 h at 45°C using the AffinityScript kit (Agilent) in a 25 µl
reaction according to the manufacturer’s instructions. Then 2 µl of cDNA
was amplified in a 20 µl reaction volume using Brilliant III ultrafast qPCR
master mix reagents (Agilent). PCR products were detected using dual-
labelled (FAM/BHQ1) hybridization probes specific to each of the cDNAs
(Eurofins). The PCR primers were: Cd40l forward, 5′-TGGATCTGAGA-
GAATCTTACT-3′ and reverse, 5′-AGTCACGTTGACAAACAC-3′; Cd40
forward, 5′-CTTTGGAGTTATGGAGATG-3′ and reverse, 5′-ATGACT-
GATTGGAGAAGA-3′; TrkA forward, 5′-CTGTGTCCATCACATCAA-3′
and reverse, 5′-GAAGGTTGTAGCACTCAG-3′; TrkB forward, 5′-AAG-
TTTGGCATGAAAGGC-3′ and reverse, 3′-ATTGGAGATGTGGTGGA-
G-3′; Gapdh forward, 5′-GAGAAACCTGCCAAGTATG-3′ and reverse,
5′-GGAGTTGCTGTTGAAGTC-3′; Sdha forward, 5′-GGAACACTCCA-
AAAACAG-3′ and reverse, 5′-CCACAGCATCAAATTCAT-3′; Hprt1
forward, 5′-TTAAGCAGTACAGCCCCAAAATG-3′ and reverse, 5′-AA-
GTCTGGCCTGTATCCAACAC-3′. Dual-labelled probes were: Cd40l,
5′-FAM-CGGCAAATACCCACAGTTCCT-BHQ1-3′; Cd40, 5’-FAM-
CCACTGAGACCACTGATACCG-BHQ1-3′; TrkA, 5′-FAM-CGCCAG-
GACATCATTCTCAAGT-BHQ1-3′; TrkB, 5′-FAM-CGGTCATCAGCA-
ACGACGAT-BHQ1-3′; Gapdh, 5′-FAM-AGACAACCTGGTCCTCAGT-
GT-BHQ1-3; Sdha, 5′-FAM-CCTGCGGCTTTCACTTCTCT-BHQ1-3,
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Hrpt1, FAM-TCGAGAGGTCCTTTTCACCAGCAAG-BHQ1-3′. Owing
to extremely low level expression ofCd40lmRNA, it was necessary to use a
nested amplification protocol, by pre-amplifying cDNA for eight cycles
with the forward primer, 5′-AAGGACTCTATTATGTCTACAC-3′ and
reverse primer, 5′-GATGAGAAGCCAACTCTG-3′ before amplification
with the Cd40l primer and probe set as described above.
Forward and reverse primers were used at a concentration of 150 nM and
dual-labelled probes were used at a concentration of 300 nM. PCR was
performed using the Mx3000P platform (Agilent) using the following
conditions: 45 cycles of 95°C for 12 s and 60°C for 35 s. Standard curves
were generated for each cDNA for every RT-PCR run, by using serial fivefold
dilutions of reverse transcribed mouse adult spleen total RNA (Zyagen).
Relative mRNA levels were quantified in four separate sets of dissected DRG
and hind limb buds for each embryonic age. Primer and probe sequences were
designed using Beacon Designer software (Premier Biosoft).
Quantification of DRG neuron numbers in vivo
The number of neurons in level-matched L4 DRG of E12 Cd40−/− and
Cd40+/+ embryos was quantified using a combined stereological and confocal
approach (Howell et al., 2002; Yoshikawa et al., 2007). The DRG were fixed
in 4% PFA and cryoprotected in 30% sucrose before being serially sectioned
at 10 μm. Sectionswere blocked in 5%BSA (Sigma-Aldrich) for 1 h andwere
then incubated overnight at 4°C with rabbit monoclonal anti-NeuN (1:500,
ab177487, Abcam) and mouse monoclonal anti-βIII-tubulin (1:500,
MAB1195, R&D Systems) in PBS containing 1% BSA. After gentle
washing with PBS, the sections were incubated with fluorophore-conjugated
secondary antibody (1:500, Alexa Fluor 488/546, Thermo Fisher Scientific)
in 1% BSA for 1 h in the dark at room temperature. Imaging was performed
using a Zeiss LSM710 confocal microscope and the number of
immunoreactive neurons were counted from the level-matched lumbar
DRGs of each genotype. Using the 10 μm serial sections containingwhole L4
DRGs at E12, the areas of DRG in each section were measured and the DRG
volume was calculated using Zen Black imaging software (Zeiss).
Immunoblotting
DRG neurons cultured at high density in 96-well plates (>5000 cells/well)
were lysed in ice-cold RIPA lysis buffer supplemented with protease and
phosphatase inhibitor cocktail mix (Sigma-Aldrich) and insoluble debris
was removed by centrifugation at 200 g. Equal quantities of protein were
run on pre-cast 4-20% SDS-PAGE gels (Bio-Rad) and were transferred to
PVDF membranes using a TransBlot Turbo Apparatus (Bio-Rad), which
were then incubated with blocking solution for 1 h at room temperature (5%
non-fat dry milk in PBS with 0.1% Tween-20; PBS-T). After washing with
PBS-T the blots were probed overnight at 4°C with rabbit anti-phospho-
ERK1/ERK2 (1:1000, ab9101, Cell Signaling Technologies), rabbit anti-
total ERK1/ERK2 (1:1000, ab9102, Cell Signaling Technologies) or mouse
anti-β-III-tubulin (1:5000, MAB1195, R&D Systems). Bound primary
antibodies were visualized with HRP-conjugated anti-mouse or anti-rabbit
secondary antibodies (1:2000,W4021 orW4011, respectively, Promega) and
Immunocruz Luminol reagent (Santa Cruz Biotechnology) and Amersham
Hyperfilm ECL (GEHealthcare Life Sciences). Densitometry was carried out
using Image Studio Lite (Li-cor Biosciences). The levels of phospho-ERK1
and phospho-ERK2 were normalized to the levels of total ERK1 and ERK2.
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Kisiswa, L., Osório, C., Erice, C., Vizard, T., Wyatt, S. and Davies, A. M. (2013).
TNFalpha reverse signaling promotes sympathetic axon growth and target
innervation. Nat. Neurosci. 16, 865-873. doi:10.1038/nn.3430
Kisiswa, L., Erice, C., Ferron, L., Wyatt, S., Osório, C., Dolphin, A. C. and
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